Vimarsana
Biggest News Aggregation in the World

Page 11 - Epic Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Epic Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Epic Sciences Today - Breaking & Trending Today

Global Immuno-Oncology Diagnostics Market Research Report - Vimarsana News

Global Immuno-Oncology Diagnostics Market Research Report

Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics, Including Executive/Consultant Guides and Customized...

Epic Sciences Raises 42M in First Close of Series F Funding - Vimarsana News

Epic Sciences Raises 42M in First Close of Series F Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

EPIC SCIENCES RAISES $43M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS - Vimarsana News

EPIC SCIENCES RAISES $43M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS

/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...

EPIC SCIENCES RAISES $42M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS - Vimarsana News

EPIC SCIENCES RAISES $42M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS

/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...

BIS Research Study Highlights the Global Liquid Biopsy Market to Reach $19.06 Billion by 2032 - Vimarsana News

BIS Research Study Highlights the Global Liquid Biopsy Market to Reach $19.06 Billion by 2032

FREMONT, Calif., May 26, 2022 /PRNewswire/ -- The global liquid biopsy market is projected to reach $19.06 billion in terms of revenue by 2032 at a CAGR of 19.83%, reveals the premium market